期刊文献+

Intellectual Property Protection and High Quality Development of Radix Glycyrrhizae for Treatment of COVID-19 被引量:6

在线阅读 下载PDF
导出
摘要 Radix Glycyrrhizae is the dominant native medicinal material variety in the north and northwestern medicinal materials producing areas.It is a main Chinese medicine of effective TCM drugs and formulas for the treatment of new coronavirus disease(COVID-19).This paper introduces the medicinal value of Radix Glycyrrhizae,involving the labeling,cultural heritage,and creative intellectual property rights of the Chinese medicinal materials,analyzes the poverty-stricken areas that are ecologically suitable for Radix Glycyrrhizae cultivation,and the superior counties and production bases of the Chinese medicinal materials.Besides,mainly from the aspects of perfect intellectual property rights,the establishment of authentic medicinal material production bases,and the construction of quality control systems,etc.,it discusses the rural revitalization strategy and the development strategy of traditional Chinese medicine(TCM),agricultural intellectual property protection and high-quality development strategy of Radix Glycyrrhizae.
出处 《Asian Agricultural Research》 2020年第5期1-6,共6页 亚洲农业研究(英文)
基金 Foundation for Key Program of Hubei Province(LX201827) Soft Science Program for Technological Innovation of Hubei Province(2018ADC149).
作者简介 Corresponding author:Yuanpeng SUN(1988-),male,master,lecturer,engaged in the research of Chinese herbal medicine resources and their intellectual property rights,Editorial Office,E-mail:asiaar@163.com。
  • 相关文献

参考文献16

二级参考文献250

共引文献455

同被引文献16

引证文献6

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部